Clinical trials
Infections trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 6 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ViiV Healthcare | 9 |
| GlaxoSmithKline | 2 |
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2 |
| National Institute of Environmental Health Sciences (NIEHS) | 2 |
| Pfizer | 2 |
| Aridis Pharmaceuticals, Inc. | 1 |
| AstraZeneca | 1 |
| Florencia Vargas-Vorackova | 1 |
| Hospital Regional Tlalnepantla | 1 |
| Instituto Mexicano del Seguro Social | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infections | 27 |
| Acquired Immunodeficiency Syndrome | 10 |
| HIV Infections | 8 |
| Pneumonia | 4 |
| COVID-19 | 3 |
| Coronavirus Infections | 3 |
| Lung Diseases | 3 |
| Respiratory Tract Infections | 3 |
| Virus Diseases | 3 |
| Bacterial Infections | 2 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.